Inhaled and exhaled nitric oxide
Inhaled and exhaled nitric oxide
复制标题
吸入和呼出的一氧化氮
DOI:
--
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
A. T. Dinh
中科院分区:
文献类型:
--
作者:
Bernard Thébaud;Jean;Jean;A. T. Dinh
Abstract. Inhaled nitric oxide (NO) is used to treat various cardiopulmonary disorders associated with pulmonary hypertension. The rationale is based on the fact that NO, given by inhalation, only dilates those pulmonary vessels that perfuse well-ventilated lung units. As a result, pulmonary gas exchange is improved while pulmonary vascular resistance is reduced and pulmonary blood flow is increased. Inhaled NO has been succesfully applied to treat persistent pulmonary hypertension of the newborn, reducing the need for extracorporeal life support. Although pulmonary hypertension and altered vasoreactivity contribute to profound hypoxaemia in adult and paediatric acute respiratory distress syndrome (ARDS), the benefit of inhaled NO still remains to be established in patients with ARDS. ARDS is a complex response of the lung to direct or indirect insults, leading to pulmonary vasoconstriction and various inflammatory responses. Recent randomized trials suggest that inhaled NO only causes a transient improvement in oxygenation. Whether this effect is important in the long-term management of ARDS remains to be established. NO, measured in the exhaled breath, is an elegant and non-invasive means to monitor inflammation of the upper and lower respiratory tract. In the normal upper airways, the bulk of exhaled NO originates from the paranasal sinuses. Exhaled NO is increased in nasal allergy and decreased in cystic fibrosis, nasal polyposis and chronic sinusitis. That NO production is increased in asthmatic airways is also well established. However, several questions still need to be addressed, in particular evaluation of the sensitivity and specificity of the measurement techniques, and assessment of the bronchodilator action of endogenous NO.
登录
查看更多内容
DOI:
10.1152/ajplung.1997.272.4.l631
发表时间:
1997
期刊:
The American journal of physiology.
影响因子:
--
作者:
McElroy,MC;Wiener-Kronish,JP;Miyazaki,H;Sawa,T;Modelska,K;Dobbs,LG;Pittet,JF
通讯作者:
Pittet,JF
影响因子:
56.9
作者:
WINK, DA;KASPRZAK, KS;KEEFER, LK
通讯作者:
KEEFER, LK
DOI:
10.1164/ajrccm.157.2.9704074
发表时间:
1998
期刊:
American journal of respiratory and critical care medicine.
影响因子:
--
作者:
Yoshihara,S;Nadel,JA;Figini,M;Emanueli,C;Pradelles,P;Geppetti,P
通讯作者:
Geppetti,P
DOI:
--
发表时间:
1997
期刊:
Journal of perinatology : official journal of the California Perinatal Association.
影响因子:
--
作者:
Kennaugh,JM;Kinsella,JP;Abman,SH;Hernandez,JA;Moreland,SG;Rosenberg,AA
通讯作者:
Rosenberg,AA
影响因子:
20.1
作者:
RobertsJr,JD;Chen,TY;Kawai,N;Wain,J;Dupuy,P;Shimouchi,A;Bloch,K;Polaner,D;Zapol,WM
通讯作者:
Zapol,WM